PLAT and ischemic stroke: Due to a small number of recent deaths reported in clinical trials, at least one of which was potentially caused by administration of tissue plasminogen activator (tPA, a common and often quick response to ischemic stroke), there should be an on-body indication of the ongoing treatment.